Treatment of hepatocellular carcinoma in a mouse xenograft model with an immunotoxin which is engineered to eliminate vascular leak syndrome

MLA

Yajun Guo, et al. “Treatment of Hepatocellular Carcinoma in a Mouse Xenograft Model with an Immunotoxin Which Is Engineered to Eliminate Vascular Leak Syndrome.” Cancer Immunology, Immunotherapy : CII, vol. 56, no. 11, Jan. 2007. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2c5ff7d4cae2726163439b7e254b2b94&authtype=sso&custid=ns315887.

APA

Yajun Guo, Sheng Hou, Shuichuan Song, Hao Wang, Geng Kou, Dapeng Zhang, Jianxin Dai, Weizhu Qian, Jian Zhao, Liang Tian, & Bohua Li. (2007). Treatment of hepatocellular carcinoma in a mouse xenograft model with an immunotoxin which is engineered to eliminate vascular leak syndrome. Cancer Immunology, Immunotherapy : CII, 56(11).

Chicago

Yajun Guo, Sheng Hou, Shuichuan Song, Hao Wang, Geng Kou, Dapeng Zhang, Jianxin Dai, et al. 2007. “Treatment of Hepatocellular Carcinoma in a Mouse Xenograft Model with an Immunotoxin Which Is Engineered to Eliminate Vascular Leak Syndrome.” Cancer Immunology, Immunotherapy : CII 56 (11). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2c5ff7d4cae2726163439b7e254b2b94&authtype=sso&custid=ns315887.